FDA Inspection 930221 — Bactolac Pharmaceutical, Inc.

Bactolac Pharmaceutical, Inc. — FEI 3000207006

The FDA completed an inspection of Bactolac Pharmaceutical, Inc. on June 25, 2015 in Hauppauge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 25, 2015
Fiscal Year
2015
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Hauppauge, NY (United States)

Citations

IDCFRDescription
1568021 CFR 111.315(d)Standard reference materials; criteria for selecting, QC
1579721 CFR 111.553Written procedures - product complaint